Apply IPO

Lets Talk About Applying IPO's Before investing.

Eris Lifesciences Ltd IPO (ELL IPO) Details

Eris Lifesciences Ltd IPO (ELL IPO) Details:

Eris Lifesciences Ltd develops, manufactures, and commercializes pharmaceutical products in chronic and acute therapeutic areas in India.

It has a portfolio of various brands in the cardiovascular, anti-diabetics, neurology, chronic respiratory, chronic pain, vitamins, gastro-intestinal, anti-infectives, gynaecology, hepatoprotectives, hormones, hematology, dermatology, anti-obesity and injury healing therapeutic areas.

The company was incorporated in 2007 and is based in Ahmedabad, India.

OBJECTS OF THE ISSUE:

The objects of the Offer are to:

  1. Achieve the benefits of listing the Equity Shares on the Stock Exchanges
  2. for the sale of up to 28,875,000 Equity Shares by the Selling Shareholders.

Eris Lifesciences Ltd IPO (ELL IPO) Details:

  1. Issue Open: June 16, 2017 – June 20, 2017
  2. Issue Type: 100% Book Built Issue IPO
  3. Face Value: Rs 10 Per Equity Share
  4. Issue Size:  28,875,000 Equity Shares of Rs 1 aggregating up to Rs 1,741.16 Cr
  5. Issue Price: Rs 600 – Rs 603 Per Equity Share
  6. Market Lot: 24 Shares
  7. Minimum Order Quantity: 24 Shares
  8. Listing At: BSE, NSE

* To Be Updated

BOOK RUNNING LEAD MANAGERS Of Eris Lifesciences Ltd IPO (ELL IPO):

Axis Capital Limited
1st Floor, Axis House, C-2, Wadia International Centre
P.B. Marg, Worli, Mumbai 400 025 Maharashtra, India
Tel: + 91 22 4325 2183 Fax: +91 22 4325 3000
E-mail: eris.ipo@axiscap.in
Investor grievance E-mail: complaints@axiscap.in

Citigroup Global Markets India Private Limited
1202, 12 th Floor, First International Financial Center
G-Block C54 & 55, Bandra Kurla Complex, Bandra
(East), Mumbai 400 098, Maharashtra, India
Tel: +91 22 6175 9999 Fax: +91 22 6175 9961
E-mail: erislifesciences.ipo@citi.com
Investor Grievance E-mail: investors.cgmib@citi.com

Credit Suisse Securities (India) Private Limited
9th Floor, Ceejay House Dr. Annie Besant Road
Worli, Mumbai 400 018 Maharashtra, India
Tel: +91 22 6777 3777 Fax: +91 22 6777 3820
E-mail: list.projectapollo@credit-suisse.com
Investor Grievance E-mail: list.igcellmerbnkg@credit-suisse.com

REGISTRAR TO THE OFFER of Eris Lifesciences Ltd IPO (ELL IPO):

Link Intime India Private Limited
C-101, 1 st Floor, 247 Park L.B.S. Marg, Vikhroli (West)
Mumbai 400 083 Maharashtra, India
Tel: +91 22 4918 6200 Fax: +91 22 4918 6195
E-mail: eris.ipo@linkintime.co.in

Eris Lifesciences Ltd IPO (ELL IPO) Red Herring Prospectus (RHP):

Eris Lifesciences IPO (ELL IPO) Prospectus

Market Update:

If You Want to Reduce Your Brokerage By More Than 80% Just Get More Information Here: Save More Than 80% Brokerage.

Housing and Urban Development Corporation Ltd IPO (HUDCO) listing is also successfully completed.

PSP Projects Ltd(PPL) IPO bidding is also over. Indigrid Invit Fund IPO bidding also able to close successfully on May 19, 2017.

Tejas Networks Ltd (TNL) IPO bidding is going to hit market from June 14, 2017 – June 16, 2017.

Central Depository Services IPO Grey Market Premium (CDSL GMP) is trading between Rs 115 – Rs 117 per equity share. While Tejas Networks Grey Market Premium (GMP) also started trading between Rs 42 – Rs 44 per equity share.

In the month of June we can expect Central Depository Services Ltd IPO (CDSL IPO) also.

Some SME IPO will also be active in market in coming week.

This year we can see some good IPO hitting market like NSE Ltd IPOHDFC Standard life insurance, SBI life insurance etc.

Keep watching this blog to keep yourself updated with all the news.

If you want all updates delivered to your email box just subscribe for the updates. We also hate spam so we are not going to share your details with anyone. So Just Subscribe and forget the tension of tracking the IPO’s. We will do it for you.

If you like to have a Chance to Win a Smart Phone just Like and share us.

1 Comment

Add a Comment
  1. Ahmedabad based Eric Lifesciences is fastest growing company. Its revenue has doubled in last five years. With good liquidity it may not require additional capital for next few years. The company having manufacturing facility in State of Assam will enjoy tax relief till yr 2024.

Leave a Reply

Your email address will not be published. Required fields are marked *

Apply IPO © 2017